Some of the best stuff we picked up around the Internet
By: Rasmus Kragh Jakobsen - May. 14, 2020
Top Picks
Sherlock Biosciencesmakes history and receives FDA authorization for a CRISPR technology product. Their CRISPR SARS-CoV-2 test kits will bring speed and precision to diagnostics in the fight against COVID19. Press release.
So well deserved! Cancer researcher and immunotherapy pioneer Carl June elected to the U.S. National Academy of Science. Earlier this year, June spoke to us on the first two CRISPR gene therapies here and here.
An illuminating interview with AAV pioneer Guangping Gao - from Chinas cultural revolution to the gene therapy revolution.
Light-controlled guide RNA hones CRISPR targeting. »In principle, multicolour targeting systems could be developed to allow different genes to be switched off simultaneously or at different times.«
Highly efficient zinc finger gene editing of Cystic Fibrosis patient-derived airway basal cells demonstrate efficient functional correction of CFTR and provide a platform for further ex vivo and in vivo editing.
Industry
CRISPR Therapeutics and Vertex Pharmaceuticals drug - CTX001 for the Treatment of Severe Hemoglobinopathies - granted FDA Regenerative Medicine Advanced Therapy (RMAT). The designation will speed development and review for the new blood-disease treatment. Press release.
Two of MilliporeSigma's CRISPR-Cas9 genome-editing patents have been allowed in the U.S. The company is licensing this foundational technology which provides researchers with tools to 'knock-in' or 'knock-out' mutations. Press release.
Lots of interesting sessions at the 23rd Annual Meeting of the ASGCT (American Society of Gene & Cell Therapy). Did You miss some? - for the registered attendees recordings are available.